CV Sciences, Inc.
CVSI
$0.03
$0.006.15%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.57% | -10.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.57% | -10.06% | |||
| Cost of Revenue | -2.44% | -5.57% | |||
| Gross Profit | 5.83% | -14.37% | |||
| SG&A Expenses | -5.57% | -4.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.22% | -5.87% | |||
| Operating Income | 72.73% | -109.92% | |||
| Income Before Tax | 46.60% | -46.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 46.07% | -46.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.07% | -46.36% | |||
| EBIT | 72.73% | -109.92% | |||
| EBITDA | 77.87% | -234.25% | |||
| EPS Basic | 47.62% | -50.00% | |||
| Normalized Basic EPS | 46.15% | -44.44% | |||
| EPS Diluted | -233.33% | -50.00% | |||
| Normalized Diluted EPS | 46.15% | -44.44% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||